Read More

Why Dermata Therapeutics Shares Are Trading Higher By Over 57%; Here Are 20 Stocks Moving Premarket

Shares of Dermata Therapeutics, Inc. (NASDAQ: DRMA) rose sharply in pre-market trading after the company announced the issuance of a new patent in Japan for its DMT410 program for the treatment of hyperhidrosis. Dermata Therapeutics shares jumped 57.3% to $0.9601 in pre-market trading.

AIMD

Read More

Retractable Technologies And 3 Other Stocks Under $3 Insiders Are Buying

The Dow Jones index closed higher by around 10 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

CDZI